cropper
National Cannabis Newswire
  • Home
  • Categories
    • news
    • trends
    • insights
    • industry
    • legalization
    • health
    • culture
    • advocacy
    • Brands
    • New Mexico Dispensaries
    • Arizona Dispensaries
3 Minutes Read

The Cannabis Business Advisors Launches Digital Platform to Support Dispensaries and Manufacturing License Holders for "DEA Readiness"

FOR IMMEDIATE RELEASE

Cannabis | Department of Justice | Federal Rescheduling | Business | E-Commerce | DEA The Cannabis Business Advisors Launches Digital Platform to Support Dispensaries and Manufacturing License Holders for "DEA Readiness"

The specialized platform provides the federal documentation templates to help medical cannabis operators strengthen compliance infrastructure as federal registration and regulatory expectations continue to evolve.

PHOENIX, Ariz. – (June 24, 2026) –The Cannabis Business Advisors (CBA), a leading strategic advisory firm, today announced the launch of an online storefront for on-demand digital compliance platform and registration support services.


CBA Photo_ Sara Gullickson


As the federal registration process moves forward and cannabis policy continues to evolve, many medical operators are taking a closer look at whether their existing compliance documentation reflects current operational practices and supports potential federal expectations.

The portal is engineered to provide immediate DEA Readiness for independent dispensaries, multi-state operators (MSOs), and vertically integrated medical cannabis businesses navigating the historic federal transition to Schedule III.

"The registration process has prompted many operators to take a closer look at their existing compliance programs," said Sara Gullickson, founder and CEO of Cannabis Business Advisors. "One of the biggest misconceptions is that having state-required SOPs automatically means you're prepared for federal review. In reality, many businesses are discovering that their documentation no longer reflects how they operate today. We built this platform to help operators strengthen that foundation with practical, ready-to-use compliance resources."

Mitigating Risks and Documentation
Obtaining a DEA registration is an intensive federal audit rather than an administrative formality. The CBA’s industry compliance assessments reveal that many operators rely on outdated state-level documentation or templates that fail to meet federal standards.

Before applying, businesses must compile documentation like comprehensive corporate ownership disclosures, detailed facility blueprints, physical floor plans, and localized zoning maps, and advanced physical security infrastructure and surveillance documentation.

Why SOPs Matter for Federal Review
Standard Operating Procedures (SOPs) are the foundation of federal compliance. Under a Schedule III framework, standardizing daily workflows proves to regulators that a facility can manage a controlled substance safely. CBA’s new platform offers specialized, downloadable SOP templates addressing:

● Airtight diversion prevention protocols that ensure product remains strictly within the legal medical supply chain.

● Dual-market inventory separation workflows designed for dual-licensed facilities to isolate Schedule III medical products from Schedule I recreational assets.

● Enhanced recordkeeping and chain-of-custody tracking models built for federal retention and instant retrievability.

Looking Ahead
Beyond compliance, proactive federal readiness serves as a major driver for enterprise valuation, positioning medical operators to legally bypass the IRS Section 280E tax restrictions.

"Federal policy will continue to evolve," Gullickson said. "The operators who will be strongest aren't simply responding to regulatory changes. They're building compliance systems that evolve alongside their businesses. That's what positions organizations for long-term success."

Operators can download the comprehensive compliance packages by visiting thecannabisbusinessadvisors.myshopify.com or emailing info@thecannabisbusinessadvisors.com.

###
About Cannabis Business Advisors
Founded in 2020, The Cannabis Business Advisors (“CB Advisors”) is a multifaceted consulting firm providing strategic business guidance for cannabis license applicants and current license holders throughout all stages of growth to companies across the U.S. and Canada. CB Advisors is led by CEO and Founder, Sara Gullickson and President Maxime Kot. The consulting team brings more than twenty years of combined industry experience. The company offers a comprehensive suite of services, including application and licensing preparation, operational analysis, merger and acquisition support, policy and procedures, exit strategy guidance, and business development planning. CB Advisors is located at 1709 E Bethany Home Road, in Phoenix, Arizona. For information, visit thecannabisbusinessadvisors.com, email info@thecannabisbusinessadvisors.com, or phone 602-290-9424.

Media Contact:
Kim Prince, Proven Media, 480-221-7995, kim@provenmedia.com

news Brands

51 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts

UK Patients Secure Temporary Bedrolite Supply Amid Ongoing Challenges

Update Exciting Developments in UK Medical Cannabis AccessIn a positive turn for UK medical cannabis patients, news has emerged that they will have access to a six-month stockpile of Bedrolite. This comes after weeks of confusion and uncertainty due to Bedrocan's recent collapse. Target Healthcare, stepping in as a local manufacturer, announced that they have secured enough inventory to ensure stability for patients navigating this challenging period. They confirmed they'll do everything possible to keep the stock flowing to those in need, providing a glimmer of hope for families relying on this crucial medication.Pioneering Cannabis Manufacturing in the UKTarget Healthcare's role in the production of Bedrolite represents a significant shift in how cannabis is sourced in the UK. After Brexit disrupted supply chains in 2022, this Glasgow-based company took initiative by producing Bedrolite locally at their Durham facility. With a commitment to upholding high standards, Target ensured that their production would align with quality check protocols established with former partners in the Netherlands.Pressures Mount for Long-Term SolutionsDespite the six-month supply assurance, the long-term future of Bedrolite remains in limbo. Patient advocacy groups and families are now clamoring for more permanent solutions. As Bedrocan's previous operations came to a halt, numerous routes are being explored for sustainable production. Discussions about a new supply chain framework are ongoing, modeled after previous agreements that allowed UK patients to access necessary medications throughout such transitions.Looking Ahead: Potential Pathways for RecoveryThe situation has opened discussions about the potential diplomatic solutions that could come from UK-Dutch relations. Experts suggest that a new licensing agreement through the Dutch Office of Medicinal Cannabis (OMC) could pave the way for renewed imports. However, this is contingent upon successful negotiations and the appointment of a reliable buyer or producer capable of fulfilling the demand.Community Voices: A Human Perspective on AccessBeyond the politics and logistics is the human element—patients relying on Bedrolite for their health. Families are advocating passionately for these necessary medications; their stories are those of resilience and hope. As Target continues its dialogue with stakeholders, the hope is to see compassion and understanding be at the forefront of healthcare decisions, ensuring that patients' needs are prioritized. Your Voice Matters: Advocating for Long-Term ChangeAs the challenges in securing long-term access to Bedrolite unfold, it's essential for the community to remain involved. Advocacy for patient needs can influence decision-making at higher levels. Joining organizations that focus on patient rights and access to medical cannabis can be a great way to make a difference. Every voice counts in the struggle for secure access to life-saving medications.

The Prime Leaf Has Been Voted Best Dispensary in Tucson Weekly’s 2026

FOR IMMEDIATE RELEASE October 22, 2026TUCSON, AZ – The Prime Leaf has been voted Best Dispensary in Tucson Weekly’s 2026 Best of Tucson readers’ poll, a recognition made especially meaningful by the community that has supported the locally owned dispensary for years. With two Tucson locations, The Prime Leaf has built its reputation on quality cannabis, friendly knowledgeable staff, and a commitment to keeping its roots firmly planted in the community. From supporting local artists, musicians, and events to giving back through community partnerships. The Prime Leaf has always believed that being a good neighbor is just as important as being a great dispensary. “This award means a lot because it comes directly from the people of Tucson. We’re proud to be locally owned, and even prouder to have a community that continues to support us, ” said Leah Rhey, Marketing Director for The Prime Leaf. As Tucson’s cannabis industry continues to evolve, The Prime Leaf remains committed to the independent, community-focused approach that has defined the business from the beginning. Rooted in Community. Voted Tucson’s Best. The Prime Leaf Midtown: 4420 E. Speedway Blvd., Tucson, AZ University: 1525 N. Park Ave., Tucson, AZ Website: www.theprimeleaf.com

The Future of US Cannabis Contracts Hangs in the Balance—What You Need to Know

Update Unpacking the Legal Quagmire of Cannabis Contracts The recent battle over cannabis contracts is not just a legal wrangle; it serves as a significant bellwether for the industry as a whole. With a Michigan cultivator, Hello Farms, challenging a troubling court decision that jeopardizes the enforceability of contracts in the cannabis sector, the stakes have never been higher. This historic ruling by the Sixth Circuit Court has cast a shadow over the legality of cannabis contracts nationwide, threatening the very foundation of state-regulated cannabis markets. Understanding the Ruling: More Than Just a Legal Setback Hello Farms' CEO Brian Farah passionately argues that the implications of this ruling extend far beyond the $31.8 million jury verdict at stake. “This isn’t just about us; it's a disastrous consequence for all independent operators in the state-legal cannabis industry,” he told Business of Cannabis. The essence of the court's verdict rests on the premise that federal illegality under the Controlled Substances Act nullifies any contracts related to cannabis supply. This sets a precarious precedent for those engaging in legal cannabis commerce, fuelling fears of 'unimaginable instability' as noted by legal experts. The Ripple Effect: What This Means for Cannabis Entrepreneurs The decision has led to urgent calls from NORML (National Organization for the Reform of Marijuana Laws) urging for a reconsideration of the ruling. The organization states that accountability in contracts gives consumers and suppliers the confidence needed in a burgeoning industry still grappling with stigma and regulatory challenges. As the court’s decision has thrust cannabis entrepreneurs into uncharted territory, many are left to ponder the sustainability of their business practices if vital contract rights can be tossed aside with a judicial gavel. Rewritten Contracts: A Proactive Strategy for Farmers and Suppliers Farah has offered invaluable advice to fellow cannabis suppliers: rethink your contracts to incorporate protective clauses that shield you from this legal vulnerability. “Consider binding arbitration outside the federal court system,” he recommends, “and include rock-solid state-court forum selection clauses to help combat the federal illegality issue.” Such proactive strategies are crucial for those hoping to ensure their businesses remain legally robust in a tumultuous landscape. A Call for Change: The Road Ahead for Cannabis Law The future of cannabis legislation remains a mixed bag as entrenched federal limitations hinder progress despite the voice of reformists like NORML. The conversation around the enforceability of cannabis contracts speaks to a larger narrative: how much does federal law stifle state-led progress? The cannabis community appears poised at a pivotal juncture that requires active participation in the legal and political arenas. As the fight unfolds, we see a familiar theme: advocates raising their voices against outdated regulations. Cannabis legalization isn’t just about enjoying the product; it's about creating a thriving, accountable market that benefits everyone. It’s essential for cannabis professionals to remain engaged in advocacy, supporting efforts to reform not only laws but the cultural perceptions surrounding the industry. While the immediate circumstances are challenging for Hello Farms, the broader implications present a unique opportunity for collective action across the cannabis community. The call to rethink contracts and engage in reform is more than a strategy; it’s a necessity for future sustainability and growth. In this uncertain climate, let us rally around the cause, amplifying the voices that advocate for a more just and equitable cannabis marketplace. As an industry, we must push for change that aligns the law with our vibrant, legitimized practices.

National Cannabis Newswire
National Cannabis Newswire keeps you informed, empowered, and connected to the Cannabis community.

COMPANY

  • Privacy Policy
  • Terms of Use
  • Advertise
  • Contact Us
  • Menu 5
  • Menu 6

480.878.1919

AVAILABLE FROM 8AM - 5PM PST

Contact

11504 W Piccadilly Rd,
Avondale, AZ 85392,

ABOUT US

Your source for breaking cannabis industry news, expert insights, and nationwide updates—National Cannabis Newswire keeps you informed, empowered, and connected.

© 2026 CompanyName All Rights Reserved. Address . Contact Us . Terms of Service . Privacy Policy

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*